These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14556240)

  • 1. Characterization of fluoxetine plus olanzapine treatment in rats: a behavior, endocrine, and immediate-early gene expression analysis.
    Horowitz JM; Goyal A; Ramdeen N; Hallas BH; Horowitz AT; Torres G
    Synapse; 2003 Dec; 50(4):353-64. PubMed ID: 14556240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat.
    Kodama M; Fujioka T; Duman RS
    Biol Psychiatry; 2004 Oct; 56(8):570-80. PubMed ID: 15476686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex.
    Zhang W; Perry KW; Wong DT; Potts BD; Bao J; Tollefson GD; Bymaster FP
    Neuropsychopharmacology; 2000 Sep; 23(3):250-62. PubMed ID: 10942849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
    Tohen M; Vieta E; Calabrese J; Ketter TA; Sachs G; Bowden C; Mitchell PB; Centorrino F; Risser R; Baker RW; Evans AR; Beymer K; Dube S; Tollefson GD; Breier A
    Arch Gen Psychiatry; 2003 Nov; 60(11):1079-88. PubMed ID: 14609883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of olanzapine and fluoxetine in mood disorders.
    Shelton RC
    Expert Opin Pharmacother; 2003 Jul; 4(7):1175-83. PubMed ID: 12831342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of olanzapine on regional C-Fos expression in rat forebrain.
    Robertson GS; Fibiger HC
    Neuropsychopharmacology; 1996 Feb; 14(2):105-110. PubMed ID: 8822533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine and fluoxetine administration and coadministration increase rat hippocampal pregnenolone, allopregnanolone and peripheral deoxycorticosterone: implications for therapeutic actions.
    Marx CE; Shampine LJ; Khisti RT; Trost WT; Bradford DW; Grobin AC; Massing MW; Madison RD; Butterfield MI; Lieberman JA; Morrow AL
    Pharmacol Biochem Behav; 2006 Aug; 84(4):609-17. PubMed ID: 16996120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of fluoxetine on olanzapine pharmacokinetics.
    Gossen D; de Suray JM; Vandenhende F; Onkelinx C; Gangji D
    AAPS PharmSci; 2002; 4(2):E11. PubMed ID: 12102620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine and olanzapine have synergistic effects in the modulation of fibroblast growth factor 2 expression within the rat brain.
    Maragnoli ME; Fumagalli F; Gennarelli M; Racagni G; Riva MA
    Biol Psychiatry; 2004 Jun; 55(11):1095-102. PubMed ID: 15158429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia.
    Wang C; McInnis J; Ross-Sanchez M; Shinnick-Gallagher P; Wiley JL; Johnson KM
    Neuroscience; 2001; 107(4):535-50. PubMed ID: 11720778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel augmentation strategy for treating resistant major depression.
    Shelton RC; Tollefson GD; Tohen M; Stahl S; Gannon KS; Jacobs TG; Buras WR; Bymaster FP; Zhang W; Spencer KA; Feldman PD; Meltzer HY
    Am J Psychiatry; 2001 Jan; 158(1):131-4. PubMed ID: 11136647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential induction of FosB isoforms throughout the brain by fluoxetine and chronic stress.
    Vialou V; Thibault M; Kaska S; Cooper S; Gajewski P; Eagle A; Mazei-Robison M; Nestler EJ; Robison AJ
    Neuropharmacology; 2015 Dec; 99():28-37. PubMed ID: 26164345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of olanzapine, fluoxetine and olanzapine/fluoxetine on creatine kinase activity in rat brain.
    Agostinho FR; Scaini G; Ferreira GK; Jeremias IC; Réus GZ; Rezin GT; Castro AA; Zugno AI; Quevedo J; Streck EL
    Brain Res Bull; 2009 Dec; 80(6):337-40. PubMed ID: 19748553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo biochemistry of olanzapine: a novel, atypical antipsychotic drug.
    Bymaster FP; Rasmussen K; Calligaro DO; Nelson DL; DeLapp NW; Wong DT; Moore NA
    J Clin Psychiatry; 1997; 58 Suppl 10():28-36. PubMed ID: 9265914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of the antidepressant-like effect of fluoxetine by aripiprazole in the mouse tail suspension test.
    Kamei J; Miyata S; Sunohara T; Kamei A; Shimada M; Ohsawa M
    J Pharmacol Sci; 2008 Nov; 108(3):381-4. PubMed ID: 18987428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of adolescent fluoxetine treatment on fear-, anxiety- or stress-related behaviors in C57BL/6J or BALB/cJ mice.
    Norcross M; Mathur P; Enoch AJ; Karlsson RM; Brigman JL; Cameron HA; Harvey-White J; Holmes A
    Psychopharmacology (Berl); 2008 Oct; 200(3):413-24. PubMed ID: 18594797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological effects of acute and chronic olanzapine and fluoxetine in the rat prefrontal cortex.
    Gronier BS; Rasmussen K
    Neurosci Lett; 2003 Oct; 349(3):196-200. PubMed ID: 12951202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic fluoxetine treatment and maternal adversity differentially alter neurobehavioral outcomes in the rat dam.
    Pawluski JL; Charlier TD; Fillet M; Houbart V; Crispin HT; Steinbusch HW; van den Hove DL
    Behav Brain Res; 2012 Mar; 228(1):159-68. PubMed ID: 22173000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impacts of early intervention with fluoxetine following early neonatal immune activation on depression-like behaviors and body weight in mice.
    Doosti MH; Bakhtiari A; Zare P; Amani M; Majidi-Zolbanin N; Babri S; Salari AA
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():55-65. PubMed ID: 23270703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine plus fluoxetine treatment increases Nt-3 protein levels in the rat prefrontal cortex.
    Agostinho FR; Réus GZ; Stringari RB; Ribeiro KF; Pfaffenseller B; Stertz L; Panizzutti BS; Kapczinski F; Quevedo J
    Neurosci Lett; 2011 Jun; 497(2):99-103. PubMed ID: 21545827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.